Mabel Bartlett
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mabel Bartlett has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Liyang Wang
Department of Materials Science and Engineering Carnegie Mellon University Pittsburgh Pennsylvania USA
2 shared publications - Tzahi Cohen-Karni
Carnegie Mellon University
2 shared publications - Bryan N. Brown
University of Pittsburgh
1 shared publication Carmel Majidi
Department of Mechanical Engineering Carnegie Mellon University Pittsburgh Pennsylvania USA
1 shared publication- Clint Skillen
Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15260, USA
1 shared publication - Daniel San Roman
Carnegie Mellon University
1 shared publication
Latest Publications
- Open Access
- 23 March 2026
- Published by Wiley in Advanced Electronic Materials
- Vol. 12 (14) , e00885
Chronic Disease Monitoring Using Advanced Compliant Materials for Bioelectronics
Chronic disease arises slowly through complex physiological factors that require continuous monitoring and treatment. Compliant bioelectronics with soft, stretchable, and tissue‐conformal designs allow for in vivo continuous monitoring through electrophysiological, mechanical, and biochemical modalities, while minimizing tissue irritation and immune system response. In this review, we discuss recent progress in material development, device design, and versatile sensing modalities that allow stable long‐term operation in dynamic biological environments. We focus on chronic electrophysiological systems for neural and cardiac recording, mechanical sensing systems for strain and pressure, and electrochemical sensors for molecular biomarkers. In addition, we examine self‐powered bioelectronics based on piezoelectric and triboelectric energy conversion mechanisms that eliminate the requirement for external batteries, whereas multimodal and closed‐loop systems combine sensing with therapeutic feedback. We consider key parameters like material biocompatibility, device flexibility, and long‐term stability that are required for chronic monitoring to maintain stable signal quality over long time periods relevant for clinical recordings. These technologies for compliant bioelectronics enable early disease diagnosis, personalized treatment and continuous intervention for patients, narrowing the gap between laboratory study and routine clinical applications.
- 23 March 2026
- Published by Wiley in Advanced Electronic Materials
- Vol. 12 (14) , e00885
Open AccessChronic Disease Monitoring Using Advanced Compliant Materials for Bioelectronics
Chronic disease arises slowly through complex physiological factors that require continuous monitoring and treatment. Compliant bioelectronics with soft, stretchable, and tissue‐conformal designs allow for in vivo continuous monitoring through electrophysiological, mechanical, and biochemical modalities, while minimizing tissue irritation and immune system response. In this review, we discuss recent progress in material development, device design, and versatile sensing modalities that allow stable long‐term operation in dynamic biological environments. We focus on chronic electrophysiological systems for neural and cardiac recording, mechanical sensing systems for strain and pressure, and electrochemical sensors for molecular biomarkers. In addition, we examine self‐powered bioelectronics based on piezoelectric and triboelectric energy conversion mechanisms that eliminate the requirement for external batteries, whereas multimodal and closed‐loop systems combine sensing with therapeutic feedback. We consider key parameters like material biocompatibility, device flexibility, and long‐term stability that are required for chronic monitoring to maintain stable signal quality over long time periods relevant for clinical recordings. These technologies for compliant bioelectronics enable early disease diagnosis, personalized treatment and continuous intervention for patients, narrowing the gap between laboratory study and routine clinical applications.
- Open Access
Wound state monitoring by multiplexed, electrochemical, real-time, localized, inflammation-tracking nitric oxide sensor (MERLIN)
Nitric oxide (NO) released endogenously by induced nitric oxide synthase (iNOS) in macrophages is a key regulatory biomarker for wound inflammation. Detecting NO directly on the wound bed is challenging due to its short half-life time (6 – 50 s), low physiological concentration (nM - µM) and interferences in the complex wound environment. Existing NO sensors suffer from limitations such as rigid substrates, single point of detection and complex measurement setup. Here we present a compliant, multiplexed, electrochemical, real-time, localized, inflammation-tracking nitric oxide sensor (MERLIN) array for in vivo spatiotemporal measurement of NO, with high sensitivity (15.6 ± 5.0 nA/μM for 1.5 mm diameter electrodes), selectivity against nitrites (ca. 27900-fold), ascorbic acid (ca. 3800-fold), and uric acid (ca. 6900-fold), and low limit of detection (8.00 nM). We developed a robust device fabrication protocol, comprehensive and highly reproducible in vitro characterization yielding a consistent device performance deployed for wound healing diagnostics. MERLIN spatiotemporally tracked NO on rat skin wounds for 7 days and results indicated that NO peaks on day 3, in line with previously reported iNOS activity. MERLIN allows spatial mapping of the NO gradient across the wound bed, which can be used to provide diagnostic information to assist wound care.
Open AccessWound state monitoring by multiplexed, electrochemical, real-time, localized, inflammation-tracking nitric oxide sensor (MERLIN)
Nitric oxide (NO) released endogenously by induced nitric oxide synthase (iNOS) in macrophages is a key regulatory biomarker for wound inflammation. Detecting NO directly on the wound bed is challenging due to its short half-life time (6 – 50 s), low physiological concentration (nM - µM) and interferences in the complex wound environment. Existing NO sensors suffer from limitations such as rigid substrates, single point of detection and complex measurement setup. Here we present a compliant, multiplexed, electrochemical, real-time, localized, inflammation-tracking nitric oxide sensor (MERLIN) array for in vivo spatiotemporal measurement of NO, with high sensitivity (15.6 ± 5.0 nA/μM for 1.5 mm diameter electrodes), selectivity against nitrites (ca. 27900-fold), ascorbic acid (ca. 3800-fold), and uric acid (ca. 6900-fold), and low limit of detection (8.00 nM). We developed a robust device fabrication protocol, comprehensive and highly reproducible in vitro characterization yielding a consistent device performance deployed for wound healing diagnostics. MERLIN spatiotemporally tracked NO on rat skin wounds for 7 days and results indicated that NO peaks on day 3, in line with previously reported iNOS activity. MERLIN allows spatial mapping of the NO gradient across the wound bed, which can be used to provide diagnostic information to assist wound care.